Literature DB >> 27065451

B cell receptor induced Fc receptor-like 5 expression is mediated by multiple signaling pathways converging on NF-κB and NFAT.

Bazarragchaa Damdinsuren1, Jessica Dement-Brown1, Huifang Li1, Mate Tolnay2.   

Abstract

Fc receptor-like (FCRL) proteins are novel regulators of the B cell response to antigen. Human FCRL5 binds intact IgG and modifies the strength of antigen receptor (BCR) signaling. Altering FCRL5 expression could therefore regulate the B cell response to antigen. In this study, we found that FCRL5 expression is induced specifically upon BCR stimulation and dissected the molecular mechanism. FCRL5 mRNA and cell surface protein expression required prolonged BCR stimulation and de novo protein synthesis. Using chemical inhibitors and activators, we identified roles for several signaling pathways, indicating a complex mechanism. Specifically, the PI3K/AKT, JNK, PKC and IKK2-dependent classical NF-κB pathways were involved in induced FCRL5 expression. Furthermore, induced FCRL5 expression required elevation of intracellular Ca(++) and was partially blocked by cyclosporine A, a calcineurin inhibitor. The importance of the transcription factors NF-κB, NFAT and CREB-binding protein was revealed based on sensitivity to inhibitors. Using reporter gene assays, we showed that the core FCRL5 promoter was sufficient to drive induced gene expression. Mutations of two predicted NF-κB sites or an NFAT site in the core promoter abrogated induced gene expression, suggesting direct regulation of the FCRL5 gene by NF-κB and NFAT. In support, we detected binding of NF-κB and NFAT family proteins to oligonucleotides corresponding to the predicted sites. We propose that the identified intricate mechanism serves to ensure that FCRL5 is expressed on B cells at a precise time following antigen encounter, with potential implications regarding regulation of the B cell response. Published by Elsevier Ltd.

Entities:  

Keywords:  B cell antigen receptor; B lymphocytes; Fc receptor-like; Signal transduction; Transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 27065451     DOI: 10.1016/j.molimm.2016.04.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells.

Authors:  L-Y Chang; Y Li; D E Kaplan
Journal:  J Viral Hepat       Date:  2016-12-20       Impact factor: 3.728

2.  Genomic deregulation of PRMT5 supports growth and stress tolerance in chronic lymphocytic leukemia.

Authors:  Ann-Kathrin Schnormeier; Claudia Pommerenke; Maren Kaufmann; Hans G Drexler; Max Koeppel
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

3.  Biomarkers from circulating neutrophil transcriptomes have potential to detect unruptured intracranial aneurysms.

Authors:  Vincent M Tutino; Kerry E Poppenberg; Lu Li; Hussain Shallwani; Kaiyu Jiang; James N Jarvis; Yijun Sun; Kenneth V Snyder; Elad I Levy; Adnan H Siddiqui; John Kolega; Hui Meng
Journal:  J Transl Med       Date:  2018-12-28       Impact factor: 5.531

4.  Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis.

Authors:  Kasia Owczarczyk; Matthew D Cascino; Cecile Holweg; Gaik W Tew; Ward Ortmann; Timothy Behrens; Thomas Schindler; Carol A Langford; E William St Clair; Peter A Merkel; Robert Spiera; Philip Seo; Cees Gm Kallenberg; Ulrich Specks; Noha Lim; John Stone; Paul Brunetta; Marco Prunotto
Journal:  JCI Insight       Date:  2020-09-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.